Do you know the warning signs of life threatening purpura? Dr. Roderick Hay outlines what you need to know about potentially life-threatening conditions involving purpura.
The biosimilars market is expected to exceed $10.9 billion by 2021, but the commercialization of biosimilars have lagged. Expert Mark Ginestro offers his insights on the top 3 biosimilar developments on 2018 and what they may mean for adoption in the coming year.
Would you like to grow your revenue while saving thousands in provider fees? Download the Ultimate Guide to Patient Financing to learn how!
Read more.
ADVERTISEMENT
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%